AU1833000A - Method for diagnosing neoplasia - Google Patents

Method for diagnosing neoplasia

Info

Publication number
AU1833000A
AU1833000A AU18330/00A AU1833000A AU1833000A AU 1833000 A AU1833000 A AU 1833000A AU 18330/00 A AU18330/00 A AU 18330/00A AU 1833000 A AU1833000 A AU 1833000A AU 1833000 A AU1833000 A AU 1833000A
Authority
AU
Australia
Prior art keywords
diagnosing neoplasia
neoplasia
diagnosing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU18330/00A
Other languages
English (en)
Inventor
Han Li
Li Liu
Rifat Pamukcu
Gary A. Piazza
W. Joseph Thompson
Bing Zhu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cell Pathways Inc
Original Assignee
Cell Pathways Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Pathways Inc filed Critical Cell Pathways Inc
Publication of AU1833000A publication Critical patent/AU1833000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU18330/00A 1998-11-25 1999-11-24 Method for diagnosing neoplasia Abandoned AU1833000A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US20002598A 1998-11-25 1998-11-25
US20066298A 1998-11-25 1998-11-25
US09200025 1998-11-25
US09200662 1998-11-25
PCT/US1999/028099 WO2000033067A1 (en) 1998-11-25 1999-11-24 Method for diagnosing neoplasia

Publications (1)

Publication Number Publication Date
AU1833000A true AU1833000A (en) 2000-06-19

Family

ID=26895400

Family Applications (1)

Application Number Title Priority Date Filing Date
AU18330/00A Abandoned AU1833000A (en) 1998-11-25 1999-11-24 Method for diagnosing neoplasia

Country Status (4)

Country Link
EP (1) EP1133689A4 (enExample)
JP (1) JP2002531826A (enExample)
AU (1) AU1833000A (enExample)
WO (1) WO2000033067A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6794192B2 (en) 2000-06-29 2004-09-21 Pfizer Inc. Target
GB0016009D0 (en) * 2000-06-29 2000-08-23 Pfizer Ltd Target

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5401774A (en) * 1991-03-08 1995-03-28 University Of Arizona Method for treating patients with precancerous lesions by administering substituted sulfonyl idenyl acetic and propionic acids and esters to patients with lesions sensitive to such compounds
DE69202721T2 (de) * 1991-03-08 1995-10-12 Fgn Inc Substituierte Indenylverbindungen.
ES2156898T3 (es) * 1993-05-27 2001-08-01 Univ Washington Materiales de fosfodiesterasa especifica de gmp ciclico que se une a gmp ciclico y procedimientos para su preparacion.
US5858694A (en) * 1997-05-30 1999-01-12 Cell Pathways, Inc. Method for identifying compounds for inhibition of cancerous lesions
IL132366A0 (en) * 1998-10-15 2001-03-19 Cell Pathways Inc Methods for identifying compounds for inhibition of neoplastic lesions and pharmaceutical compositions containing such compounds

Also Published As

Publication number Publication date
JP2002531826A (ja) 2002-09-24
EP1133689A4 (en) 2002-10-30
WO2000033067A1 (en) 2000-06-08
EP1133689A1 (en) 2001-09-19

Similar Documents

Publication Publication Date Title
AU696462B2 (en) Diagnostic method
AU2869799A (en) Diagnostic method for analyzing emboli
AU1647200A (en) Method for receiving spread-spectrum signals
AU5064499A (en) Method for determining hemoglobins
AU3590199A (en) Method for diagnosing a vascular condition
AU6105199A (en) Diagnostic method
AU4797997A (en) Method for qos measurement
AU5507199A (en) Method for oxidizing hydrocarbons
AU6138500A (en) Method for measuring loss
AU2314099A (en) Secure exam method
AU1704000A (en) Method for diagnostic screening
AU1390600A (en) Method for making polyester
AU1833000A (en) Method for diagnosing neoplasia
AU6000600A (en) Diagnostic method
AU2194801A (en) Diagnostic method
AUPP612798A0 (en) Diagnostic method
AU1984900A (en) Diagnostic method
AU4727899A (en) A method for diagnosing selected adenocarcinomas
AU2813797A (en) Method for diagnosing cancer
AU4901599A (en) Method for producing phytosqualane
AU1775600A (en) Method for producing pyrimidopteridines
AUPO933597A0 (en) Diagnostic method
AU1390700A (en) Method for making polyester
AU3035800A (en) Method for producing 3-isochromanone
AU5978899A (en) Method for producing mono- or di-organo-boranes

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase